BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma

Jul 18, 2018

BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma Elena Porcù, Francesca Maule, Daniele Boso, Elena Rampazzo, Vito Barbieri, Gaia Zuccolotto, Antonio Rosato, Chiara Frasson, Giampietro Viola, Allesandro Della Puppa, Giuseppe Basso, Luca...

Somatic mutations in specific and connected sub-pathways are associated to short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease

Jul 16, 2018

Somatic mutations in specific and connected sub-pathways are associated to short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease Maria Rosaria Esposito, Andrea Binatti, Marcella Pantile, Alessandro Coppe, Katia Mazzocco, Luca...

Could the interaction between LMX1B and PAX2 influence the severity of renal symptoms?

Jul 12, 2018

Could the interaction between LMX1B and PAX2 influence the severity of renal symptoms? Negrisolo S, Carraro A, Fregonese G, Benetti E, Schaefer F, Alberti M, Melchionda S, Fischetto R, Giordano M, Murer L European Society of Human Genetics 2018

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Jul 10, 2018

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial Gianni Bisogno, Meriel Jenney, Christophe Bergeron, Soledad Gallego Melcón, Andrea Ferrari, Odile...

Dr Laura Rigon was awarded the “2° Premio Triennale Hic Labor 2017 – Catergoria Materie Scientifiche e Tecniche” prize

Jul 9, 2018

On June 23rd, Dr. Laura Rigon, a member of the laboratory “Diagnosis and Therapy of Lysosomal Disorders“, was awarded the “2° Premio Triennale Hic Labor 2017 – Catergoria Materie Scientifiche e Tecniche” prize for her PhD thesis entitled “Nanotechnologies for CNS drug...